Skip to the page

Data / Drug companies / Ropivacaine hydrochloride

Ropivacaine hydrochloride: 20 companies and 79 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Ropivacaine hydrochloride is listed in the FDA National Drug Code Directory by 20 companies, with 79 products in commercial distribution. 67 of the products (84.8%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; injection, and the newest product started marketing on June 1, 2026.

The request: Get every company that lists ropivacaine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
20
Products
79
Generic (ANDA) products
67 (84.8%)
Application numbers
12
Routes
Epidural, Infiltration, Perineural
Brand names
Naropin, Naropin
openFDA record search
api.fda.gov

Companies that list ropivacaine hydrochloride

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Fresenius Kabi USA, LLC11injection, solutionNew drug applications (NDA)August 4, 2009
Eugia US LLC7injection, solutionGeneric drugs (ANDA)September 15, 2016
Hikma Pharmaceuticals USA Inc.7injection; injection, solutionGeneric drugs (ANDA)November 18, 2025
Meitheal Pharmaceuticals Inc.7injection, solutionGeneric drugs (ANDA)July 30, 2024
Somerset Therapeutics, LLC7injectionGeneric drugs (ANDA)June 15, 2018
Baxter Healthcare Corporation6injection; injection, solutionGeneric drugs (ANDA)January 1, 2024
Caplin Steriles Limited6injectionGeneric drugs (ANDA)June 24, 2025
Glenmark Pharmaceuticals Inc., USA5injection, solutionGeneric drugs (ANDA)October 8, 2025
Amneal Pharmaceuticals LLC4injectionGeneric drugs (ANDA)March 17, 2023
Anthea Pharma Private Limited3injection, solutionGeneric drugs (ANDA)March 21, 2025
Sagent Pharmaceuticals3injection, solutionGeneric drugs (ANDA)January 1, 2020
Gland Pharma Limited2injection, solutionGeneric drugs (ANDA)August 18, 2022
Mylan Institutional LLC2injection, solutionGeneric drugs (ANDA)March 18, 2024
Sola Pharmaceuticals, LLC2injection, solutionGeneric drugs (ANDA)December 1, 2024
Sportpharm LLC2injection; injection, solutionGeneric drugs (ANDA)June 15, 2018
Armas Pharmaceuticals Inc.1injectionGeneric drugs (ANDA)June 1, 2026
Civica, Inc.1injectionGeneric drugs (ANDA)September 19, 2022
Fresenius Kabi USA, LLC1injection, solutionGeneric drugs (ANDA)December 10, 2024
Henry Schein, Inc.1injection, solutionNew drug applications (NDA)January 13, 2022
ProPharma Distribution1injectionGeneric drugs (ANDA)June 15, 2018

Dosage forms

Dosage formProductsShare
Injection, solution5063.3%
Injection2936.7%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)6784.8%
New drug applications (NDA)1215.2%

Pharmacologic classes

ClassProducts
Amide Local Anesthetic79

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.